Galectin Therapeutics Inc. (NASDAQ:GALT)

CAPS Rating: 1 out of 5

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar pchop123 (76.59) Submitted: 8/10/2012 11:44:22 AM : Underperform Start Price: $2.32 GALT Score: +3.66

Read between the lines !!!

Featured Broker Partners


Advertisement